Published: 2021-06-15 09:43 | Updated: 2021-06-18 15:11

KI awarded grant for follow-up studies of COVID-19 vaccines

Person with gloves holds vaccine syringe.
Two research environments from Karolinska Institutet have been awarded grants for follow-up studies of COVID-19 vaccines. Foto: Getty Images

Two research environments from Karolinska Institutet have been awarded grants for follow-up studies of COVID-19 vaccines. In total, six research environments from five universities will share SEK 100 million from the Swedish Research Council. The research environments are based on collaborations between different regions, and will focus on different aspects of health and medical care needs.

Research projects from KI that have been awarded grants:

FASTER – National COVID-19 vaccine research platform

A national platform for research into COVID-19 vaccine will be established. Register-based research and clinical trials will form the basis for the evaluation of immune system response, safety and effectiveness of vaccines. The research platform will be a part in the EU collaboration on research into COVID-19 vaccine, VACCELERATE. A national quality register for SARS-CoV-2 will also be established.

Four regions are participating. Pontus Naucler at the Department of Medicine, Solna, is the project leader.

More about the VACCELERATE project
 

COVID-19 vaccination in immuno-suppressed individuals: An interdisciplinary collaboration to obtain clinical and mechanistic insight into lasting immunity against SARS-CoV-2 infection

The study will investigate whether patients with immune system impairment diseases can develop long-term immunity following COVID-19 vaccination, and whether they experience specific side effects. National registers should also be used to examine whether they receive protection against severe covid-19.

Four regions are participating. Soo Aleman at the Department of Medicine, Huddinge, is the project leader.